Arend Voorman (A Voorman)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Risk Assessment

Top Venues

Science (New York, N.Y.)

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Arend Voorman, Hil Lyons, Faisal Shuab, Usman S Adamu, Charles Korir, Tesfaye Erbeto, Ananda Sankar Bandyopadhyay, Samuel Okiror
Evaluation of novel oral polio vaccine type 2 SIA impact in a large outbreak of circulating vaccine-derived poliovirus in Nigeria. The Journal of infectious diseases (2023)
G R Macklin, Kathleen M O'Reilly, Nicholas C Grassly, W J Edmunds, O Mach, R Santhana Gopala Krishnan, Arend Voorman, J F Vertefeuille, J Abdelwahab, N Gumede, A Goel, S Sosler, J Sever, Ananda Sankar Bandyopadhyay, Mark A Pallansch, R Nandy, P Mkanda, O M Diop, R W Sutter
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science (New York, N.Y.) 368 (6489) (2020)
Kia Guarino, Arend Voorman, Maxime Gasteen, Donte Stewart, Jay Wenger
Violence, insecurity, and the risk of polio: A systematic analysis. PloS one 12 (10) (2017)